Arkolith/Insider Trading/ADVM/Form 4

Tuckson Reed Vaughn

DirectorAdverum Biotechnologies, Inc. (ADVM) · full profile →Form 4 · filed Dec 10, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2025Disposed to issuer(D)10K——0
Dec 9, 2025Disposed to issuer(D)5K——0
Dec 9, 2025Disposed to issuer(D)4K——0
Dec 9, 2025Disposed to issuer(D)4K——0
Dec 9, 2025Disposed to issuer(D)11K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001511051-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML